NEU - Neuren Pharmaceuticals Limited - Strawman: ASX share price, valuation, research and discussion

Top member reports

Company Report

Last edited one year ago

ranked

#81

Performance (40m)

-2.6% pa

Followed by

Straws

Sort by:

Recent

Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.

Become a member

#Q3 & Q4 ACADIA Results

stale

Added one year ago

Acadia just released Q3 results and Daybue sales were $66.9m with Q4 sales of Daybue anticipated to be $80-$87.5m

Very solid on the high side of estimates.

Disc Held

Neuren Pharmaceuticals Limited